Early Stage Mesothelioma Prognosis, Survival Rates For Mesothelioma

Patients diagnosed at an early stage of mesothelioma will have more treatment options and a better prognosis than those diagnosed at a later stage.

Notable mesothelioma victims. There is no cure for mesothelioma even in the earliest stage. However stage 1 mesothelioma has the best prognosis and is the most treatable. Patients with early stage mesothelioma have a life expectancy of 22 months while late stage patients live an average of 14 months.

In some cases patients may be diagnosed with rare cell types which also result in varied survival times. New tools including the mesomark assay measure the number of mesothelioma cells in the bloodstream possibly detecting the presence of disease long before symptoms begin. Did you know patients with stage 1 mesothelioma have a median survival time of 212 months.

While there is no cure for any stage of mesothelioma stage 1 offers the most aggressive surgical treatment options. Prognosis by mesothelioma stage. Staging can also help physicians predict how a patients condition may progress.

Early detection dramatically increases a patients outcome because the disease can be caught in the early stages. Early stage mesothelioma has no major symptoms and is often detected by accident when a doctor is looking for another illness. The prognosis for biphasic patients typically falls in between the two types differing based on which cell type is dominant.

Stage 1 mesothelioma has a better prognosis than when the cancer is diagnosed in its later stages. Most mesothelioma diagnoses dont meet this standard but for those that do there is the possibility of slowing the disease substantially. Once mesothelioma metastasizes spreads and reaches a later stage treatments such as surgery may not be viable.

Because patients diagnosed early are usually able to undergo curative surgery stage 1 mesothelioma has the best prognosis of all four stages. Overall survival is almost the same as typical life desires for early stage mesothelioma the study noted extended survival time without disease progression when compared with standard treatment. The average prognosis for stage 1 mesothelioma is 20 months although patients who receive surgical treatment have survival rates of around 30 months.

About 52 of peritoneal mesothelioma patients who are eligible for surgery with heated chemotherapy live at least five years. Stage 1 mesothelioma patients have an average life expectancy of 21 months or longer.